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• Perioperative morbidity and mortality in CLD patients
undergoing non-hepatic abdominal surgery remain high
• Stringent assessment and risk  in the
preoperative period are essential for better outcomes
• Severity of liver disease, type of surgery and whether
surgery is performed as a routine or emergency 
procedure are major determinants of outcomes
• CTP score and MELD score may be complementary
rather than competitive in predicting short term outcomes
• Preoperative portal decompression (TIPSS) may help
reduce operative bleeding and postoperative ascites
stratification
Journal of Hepatology 20
Keywords: Cirrhosis; Surgery; Outcomes; Scoring systems; Transjugular intrahe-
patic portosystemic shunt (TIPS).
Received 28 June 2011; received in revised form 8 March 2012; accepted 10 March
2012
⇑ Corresponding author. Address: Centre Hépato-Biliaire, Hôpital Paul Brousse,
Assistance Publique-Hôpitaux de Paris (AP-HP), 12 Avenue Paul Vaillant Coutu-
rier, 94804 Villejuif, France. Fax: +33 1 45 59 38 57.
E-mail address: daniel.azoulay@pbr.aphp.fr (D. Azoulay).
Abbreviations: CLD, chronic liver disease; LT, liver transplantation; CTP score, C-
hild Turcotte Pugh score; MELD, Model for End stage Liver Disease; HCV, hepatitis
C virus; HBV, hepatitis B virus; NAFLD, non alcohol related fatty liver disease;
NASH, non alcoholic steatohepatitis; INR, international normalized ratio; ASA,
American Society of Anesthesiologists; PHT, portal hypertension; TIPS, transju-
gular intrahepatic portosystemic shunt.Introduction
Patients with poorly compensated chronic liver disease (CLD),
requiring surgical intervention form a unique group of surgical
candidates. Though liver resection for hepatic tumours and liver
transplantation (LT) are the most common surgical procedures
performed in cirrhotic patients; these patients may frequently
require other non-hepatic surgical procedures including surgery
for abdominal wall hernia’s, abdominal surgery for peptic ulcer
disease, biliary, small bowel, colon, and pancreatic disease, and
in addition cardiac, vascular, and orthopaedic surgery. Patients
with compromised liver function are known to decompensate
due to the stress of both anaesthesia and surgery, and in spite
of signiﬁcant advances in surgical and intensive care, periopera-
tive mortality and morbidity continue to remain high [1–10].Studies reporting the occurrence of, and type of morbidity in
patients with cirrhosis undergoing non-hepatic surgery have
shown variable results; the reported in-hospital mortality rates
after various non-transplant surgical procedures range from
8.3% to 25% (even in well selected cirrhotic patients) compared
to 1.1% in non-cirrhotic patients [5,6]. Mortality is the conse-
quence of a high rate of postoperative decompensation of cirrho-
sis (especially in cases of intra-abdominal surgery) and an
increased risk of bacterial infection. In addition, the outcomes
are known to be worse in patients undergoing surgery as an
emergency procedure (e.g. for bleeding, perforation, incarcera-
tion) [6–10]. The wide variations in mortality rates can be attrib-
uted primarily to the varying degree of liver dysfunction, and in
addition to different patient demographics, varied surgical diag-
noses, different levels of expertise of the surgical anaesthesia
and intensive care unit team and ﬁnally, reporting bias.
The drawbacks of studies in literature include lack of control
groups in most studies [2–5,7–10], comparison of morbidity
and mortality for speciﬁc procedures rather than an overall
assessment [11–19], small number of patients in some studies,
and lack of sufﬁcient details regarding severity of liver disease
(i.e., CTP (Child Turcotte Pugh) or MELD (Model for End Stage
Liver Disease) score) [6,7,18,20–23].
It is indeed difﬁcult to signiﬁcantly reduce the operative risk
in decompensated CLD patients in most situations; hence it is
of prime importance to assess these patients in the preoperative
period and if possible predict the extent of risk of a surgical inter-
vention. Retrospective studies have identiﬁed multiple clinical
and laboratory variables that contribute to increased periopera-
tive morbidity and mortality rates in CLD patients undergoing
non-hepatic abdominal surgery [5,7–8]. Moreover, it has been
shown that there is a correlation between the number of risk fac-
tors identiﬁed by multivariate analyses and the rate of perioper-
ative complications [5]. However, the debate on the best method
(scoring systems or non hepatic markers) and then the best indi-
vidual parameters for risk assessment still continues.
This review explores methods that could best serve to assess
patients with cirrhosis preoperatively and predict outcomes of
non-hepatic surgery in them, particularly for the most common
abdominal procedures. This knowledge could help in a better
selection of patients, thus reducing postoperative mortality and
morbidity; and at the same time explore the possibility of using
preoperative interventions to further reduce these risks.
 2012 European Association for the Study of the Liver. Published
by Elsevier B.V. All rights reserved.12 vol. 57 j 874–884
JOURNAL OF HEPATOLOGY
Pathophysiology
The worldwide prevalence of CLD is increasing due to the
increasing incidence of hepatitis C (HCV), hepatitis B (HBV), alco-
hol-related and non-alcohol related fatty liver disease (NAFLD).
Up to 10% of patients with cirrhosis are likely to undergo non-
transplant surgery in the last 2 years of their life [24].
While some studies have shown that in expert hands, even
major abdominal surgeries like pancreaticoduodenectomy for
pancreatic tumours are safe in well compensated CLD patients
[25], general anaesthesia and surgery may lead to drastic morbid-
ity and high perioperative mortality in decompensated cirrhotic
patients.
Severity of liver disease (degree of decompensation) is thus
the most important factor predicting postoperative outcome. Sec-
ondary to the loss of hepatic reserve and because of other sys-
temic derangements that are the result of liver dysfunction
(such as hemodynamic impairments), patients with liver disease
have an inappropriate response to surgical stress. These individ-
uals are accordingly at an increased risk of bleeding, infection,
postoperative hepatic decompensation, including hepatic coma
or death. Therefore, the decision to perform surgery in these
patients must be heavily weighed and careful patient selection
is mandatory.
The underlying disease and nature of the surgical procedure
are important determinants of postoperative outcomes. The mor-
bidity and mortality risks are the highest in patients undergoing
cardiac surgery (up to 31% perioperative mortality), and open
abdominal surgeries like cholecystectomy (up to 17% periopera-
tive mortality), gastric resection (up to 78% morbidity, 54% mor-
tality) and colectomy (up to 48% morbidity, 24% mortality) [18].
The higher incidence of complications in abdominal surgery is
probably explained by hepatic ischemia and an increased risk
of intra-operative bleeding in the presence of portal hypertension
(PHT), especially in patients with previous abdominal surgery
and adhesions. Hemodynamic changes, characterized by
increased cardiac output, splanchnic vasodilation, and decreased
systemic vascular resistance, are common in patients with PHT,
and these changes progress with worsening liver disease. Despite
an increased cardiac output, perfusion may be impaired due to
shunting of blood, and in addition, anesthetic agents may also
reduce hepatic blood ﬂow and decrease oxygen uptake by the
liver and splanchnic organs. Hypotension, hypoxemia, hemor-
rhage and use of vasoactive drugs may further reduce hepatic
oxygenation. Hepatic blood ﬂow and liver function may be fur-
ther compromised by catecholamine release and other neurohor-
monal responses [19,26,27].
Emergency surgery has also been shown to be associated with
a higher morbidity and mortality (50% vs. 18%) as compared to
elective surgery in several studies [3,7,23]. A study comparing
the MELD and CTP scores in 40 cirrhotic patients who required
either elective or emergency surgery with general anesthesia,
found that emergency surgery was associated with signiﬁcantly
higher one- and three-month mortality rates. There was good
correlation between the CTP and the MELD scores in predicting
mortality, especially in the emergency surgery group [21].
In addition to the above, the etiology of cirrhosis in the patient
is known to have a major inﬂuence on the postoperative out-
come. A particularity of alcoholic cirrhosis is that the majority
of patients with high disease severity indexes also have superim-
posed alcoholic hepatitis (most likely due to continued active
alcohol consumption). Alcoholic hepatitis is a potentially revers-Journal of Hepatology 201ible condition, which means that some of these patients are likely
to improve within the ﬁrst few months following discontinuation
of alcohol. Hence, patients who have been abstinent for a pro-
longed period of time are likely to have better postoperative out-
comes compared to those with continued alcohol abuse. It has
also been shown that patients with HCV-related CLD undergoing
liver resection (curative treatment) for hepatocellular carcinoma
tend to do worse postoperatively as compared to those with HBV-
related CLD, ethanol-related CLD or non-alcoholic steatohepatitis
(NASH) [28,29].Main indications for extrahepatic abdominal surgery in
patients with cirrhosis: Associated morbidity, mortality, and
alternatives to surgery
Gallstone disease
Prevalence of gallstone disease (GSD) in the cirrhotic patient is
higher than in the general population, reaching 17–28%. Our cen-
ter earlier reported the prevalence and incidence of signiﬁcant
complications of GSD in CLD patients [30]. We found that 17%
of admitted CLD patients had cholelithiasis. In 22% of these
patients, cholelithiasis caused cholecystitis, obstructive jaundice,
or biliary pain, all the patients underwent a cholecystectomy. In
the other 78%, cholelithiasis was asymptomatic, 20% of these
patients died from liver failure, and the stones were discovered
at necropsy. 14% had radiographically demonstrated stones that
were not operated on, they had no complications on follow-up.
In the remaining patients, the stones were discovered during por-
tosystemic shunt procedures. Our study thus conﬁrmed the high
incidence of GSD in cirrhotic patients, and in addition, we found
that complications of GSD requiring an emergency operation
were associated with a higher risk of morbidity and mortality.
In a recent national study from the United States, the inci-
dence of four index operations (cholecystectomy, colectomy,
abdominal aortic aneurysm repair, and coronary artery bypass
grafting) performed in CLD patients was studied over a 8-year
period (from 1998 to 2005). Patients were grouped according to
the presence of cirrhosis and PHT [23]. 22,569 patients with cir-
rhosis (of whom 4214 had PHT) underwent one of the four index
operations. Patients with cirrhosis and those with cirrhosis com-
plicated by PHT most frequently underwent cholecystectomy
(63% and 58%, respectively). This was followed by colectomy,
CABG and AAA repair, in that order. Hence, this study also con-
cluded that GSD seems to be the most common extrahepatic dis-
ease that CLD patients have and are operated on.
Cirrhosis with cardiovascular disease is the main risk factor
for postchlecystectomy mortality. In Child A and B patients, lap
cholecystectomy (the preferred approach now) is feasible with
5–10% morbidity and 0–1% mortality [11,31]. On the contrary,
for the Child C patient, cholecystectomy is associated with a pro-
hibitive death rate of 23–50% [32]; severe liver failure, acute cho-
lecystitis, and emergency surgery are common in this type of
patient. Most authors agree that medical treatment should be
offered in this situation. If the medical approach is unsuccessful,
or should pyocholecystitis develop, percutaneous cholecystos-
tomy could be a solution [33].
Three studies reported on the management of common bile
duct (CBD) stones in cirrhotic patients. In the French association
report, morbidity in 31 patients undergoing surgery for CBD
stones was 29% with a mortality rate of 9.6%. Presence of CBD2 vol. 57 j 874–884 875
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stones was an important factor with major impact on morbidity
and mortality following surgery for gallstones in cirrhotic
patients [34]. Two studies conﬁrmed the beneﬁts of endoscopic
sphincterotomy (ES) over surgery for CBD stones [35,36], thus
ES followed by elective laparoscopic cholecystectomy has
become the gold standard for CBD stones. However, there is a
7% risk of mortality even with ES. Due to this, some centers have
proposed balloon endoscopic sphincteroclasia to avoid risk of
bleeding in cirrhotic patients, particularly Child C patients with-
out secondary cholecystectomy [37].
Abdominal wall hernias
Umbilical and incisional hernias are more common in cirrhotic
patients than in the general population. Abdominal distension
caused by ascites and loss of muscle mass secondary to a poor
nutritional status are the main risk factors. In the cirrhotic
patient, the incidence of abdominal wall hernia is 16% and
reaches 24% in the presence of ascites. More than half of all her-
nias are umbilical; the rate is 4-fold higher in patients with asci-
tes [38].
In the series reported by the French Association of Surgery,
which included 81 patients who underwent surgical treatment
for umbilical hernia, overall mortality was 5%: 11% after emer-
gency surgery for ruptured or strangulated umbilical hernia and
2% after elective surgery [39]. Mortality was zero in the two most
recent studies reported by expert centers, including 39 and 40
patients respectively, undergoing surgery for umbilical hernia
[15,40].
In patients with Child A or B cirrhosis, cure for inguinal hernia
was achieved with acceptable morbidity (no major complications
and four minor, readily correctable complications), 8% recurrence
rate, and a mortality rate of 5.7% in a large series of 915 patients
[41] .
Ammar et al. [42] reported results of a randomised control
trial aimed at evaluating the use of polypropylene mesh to treat
complicated umbilical hernias in cirrhotic patients. Forty patients
each underwent a conventional fascial repair or mesh hernio-
plasty. Hernia recurrence was signiﬁcantly less in the mesh her-
nioplasty group, no mesh exposure or ﬁstulae were experienced,
and there was no need to remove any of the meshes. The authors
concluded that permanent mesh can be used in complicated her-
nias in cirrhotic patients with minimal wound-related morbidity
and a signiﬁcantly lower rate of recurrence.
Appendix and colorectal surgery
In a study by Tsugawa et al. [43], comparing outcomes of open
appendectomy (OA) and laparoscopic appendectomy [LA] for
acute appendicitis in CLD patients, postoperative pain and length
of hospital stay were signiﬁcantly lesser in the LA group, so were
the number of wound infections and wound bleeding. The overall
costs were similar. The authors concluded that LA may be supe-
rior to OA in terms of postoperative pain and postoperative com-
plications for CLD patients.
Two large series have reported results of colorectal surgery
(predominantly for diverticular disease and colorectal cancer)
in CLD patients [44,45]. The reported mortality rate was 13–
23% and morbidity was 46–51%. The factors predictive of
perioperative mortality were elevated serum bilirubin levels,
low prothrombin level, ascites (Child B and C patients), and876 Journal of Hepatology 201emergency surgery. The outcomes are known to be worse in
patients undergoing surgery as an emergency procedure (e.g.,
for intestinal obstruction, bleeding, perforation) [6–10]. In the
emergency situation, colonic stenting for patients with intestinal
obstruction and endoscopic management in patients with bleed-
ing from an ulcer or tumour would be preferred to surgery.
In a recent study by Lian et al. [46], CLD patients with primary
sclerosing cholangitis (PSC) and inﬂammatory bowel disease
(IBD) who underwent a restorative proctocolectomy have been
studied. Most patients were Child Pugh class A or early B, and
eight patients were on the orthotopic liver transplantation list.
Indications for colectomy included dysplasia, failure or complica-
tions of medical therapy, cancer, and colonic perforation at
colonoscopy. 82.6% of the patients developed postoperative
complications, and 34.8% of the patients had worsening liver
function. Two patients, both after total proctocolectomy/IPAA
(ileal pouch-anal anastomosis), died of septic shock after pelvic
abscess in the postoperative period. Two patients underwent
transjugular intrahepatic portosystemic shunt (TIPS) procedure
before total proctocolectomy/IPAA; none developed pelvic
abscess or mortality. There were no differences in mortality or
morbidity between patients who underwent an ileoanal pouch
procedure or colectomy with ileostomy. The authors concluded
that colectomy in patients with IBD complicated with cirrhotic
PSC is associated with a high early postoperative morbidity rate.
In addition, strategies to reduce pelvic sepsis should be adopted,
especially after IPAA, because pelvic sepsis is associated with
higher mortality and morbidity.
Gastric surgery
Peptic ulcers are more common in CLD patients, affecting 8–20%
of them [16,47]. The mortality of emergency surgery for compli-
cated peptic ulcer (bleeding or perforation) in CLD patients is
very high ranging from 23% to 64%. Prognostic factors having
an inﬂuence on mortality are CTP class and presence of ascites
[3,16]. Laparoscopic suture of the perforated ulcer combined with
proton pump inhibitors and endoscopic haemostatic techniques
for bleeding ulcers have reduced the need for resectional surgery
and reduced the mortality in the emergency setting.
Surgical treatment of gastric cancer in cirrhotic patients
resulted in a morbidity rate of 20–26% and mortality of 0–10%
in two studies from Japan [48,49]. The French study reported a
mortality of 23%, signiﬁcantly higher in patients with ascites
and low serum albumin, and a morbidity of 56% [50]. The conclu-
sions from these studies suggest that for CTP A and B patients,
surgery is safe, but it would be preferable to propose type D1 dis-
section and to avoid dissection of the hepatic pedicle because of
the risk of lymphatic ascites.
Pancreatic surgery
Sethi et al. [25] reported four patients with pancreatic tumours
and well compensated cirrhosis, who successfully underwent
pancreaticoduodenectomy with radical lymphadenectomy. They
concluded that in expert hepatobiliary centers, pancreaticoduo-
denectomy is not contraindicated in patients with cirrhosis.
In a study that aimed at detailing the overall prevalence of
pancreatic surgery in CLD [51], a total of 35 patients were
included; 17 underwent surgery for chronic pancreatitis, three
for acute pancreatitis, 14 for malignant tumours, and one for a2 vol. 57 j 874–884
Table 1. Mortality rates associated with speciﬁc types of surgery in patients
with cirrhosis [3,7,18,20,44,55,71,98]. Includes emergency and elective proce-
dures. Adapted from: Friedman LS. ‘‘Surgery in the patient with liver disease’’.
Trans Am Clin Climatol Assoc 2010;121:192–204.
Type of surgery Mortality
Overall
(%)
Child-Pugh class MELD 
scoreA (%) B (%) C (%)
Appendectomy 9 n.a. n.a. n.a. n.a.
Cardiac 16-17 0-3 42-50 100 n.a.
Cholecystectomy 1-3 0.5 3 n.a. <8 = 0% ≥8 = 6%
Colorectal cancer 
surgery 12.5 6 13 27 n.a.
Esophagectomy 17 n.a. n.a. n.a. n.a.
Major abdominal 
surgery 26-30 10 30-31 76-82 n.a.
n.a., not available.
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benign tumour. The procedures included nine resections, includ-
ing three distal pancreatectomies, two pancreaticoduodenecto-
mies, two ampullectomies and two atypical resections for acute
pancreatitis. Among the other 26 patients, seven underwent gas-
trojejunostomy, 13 had a bilioenteric bypass, and 10 underwent a
pancreaticoenteric bypass. Overall morbidity was 51% and mor-
tality was 20%. All three patients who had emergency procedures
died, and all deaths occurred in patients in whom the gastrointes-
tinal tract was opened. These ﬁndings suggested that endoscopic
(stent, endoscopic cystogastrostomy, ampullectomy) and radio-
logic (percutaneous drainage of pancreatic abscesses) treatments
should be preferred in cirrhotic patients with an inﬂammatory
disease or tumour of the pancreas. The rare indications for resec-
tion should be reserved for elective procedures in Child Pugh A
patients without elevated transaminases (as these were found
to be independently predictive of death on univariate analysis).
A case-control study by Warnick et al. [52] compared out-
comes in 32 cirrhotic patients (30 CTP A and 2 CTP B) vs.matched
controls (operated patients without cirrhosis) undergoing pan-
creatic resection surgery. In their study, patients with cirrhosis
experienced signiﬁcantly more complications especially major
complications (47 vs. 22%; p = 0.035) requiring reoperation (34
vs. 12%; p = 0.039). These patients also had a signiﬁcantly pro-
longed hospital and ICU stay, and required twice as many trans-
fusions. Overall, three patients died following surgery, one with
Child A (3% of all Child A patients) and two with Child B cirrhosis.
The authors concluded that pancreatic surgery is associated with
an increased risk of postoperative complications in patients with
liver cirrhosis, and is therefore not recommended in patients with
Child B cirrhosis. In Child A cirrhotic patients the mortality is,
however, comparable to non-cirrhotic patients. In addition, due
to the demanding medical efforts that these patients require, they
should be treated exclusively in high-volume centers.Risk stratiﬁcation: What could be the ideal method to predict
risk and outcomes?
Scoring systems for liver function? CTP score or MELD?
The CTP and MELD scores have been the prognostic scoring mod-
els predominantly used for assessing the severity of liver disease
and for risk stratiﬁcation.
The CTP score includes ﬁve parameters, three of them being
objective (serum bilirubin, serum albumin, and prothrombin
time), and two subjective (presence of ascites and encephalopa-
thy) [53]. The score ranges from 5 to 15, and patients are further
classiﬁed into three CTP classes, A (CTP score 5–6), B (CTP score
7–9), and C (CTP score 10–15).
Based on studies published to date, it has been suggested that
elective surgery is tolerated well in CTP A patients, it is permissi-
ble with good preoperative preparation in CTP B patients (except
those undergoing major hepatic resection or cardiac surgery) and
contraindicated in CTP C patients. Two of the most important
studies, carried out 13 years apart, reported nearly identical
results: perioperative mortality rates for patients undergoing sur-
gery were 10% for CTP A, 30% for CTP B, and 80% for CTP C patients
[3,7]. With respect to cardiac surgery, the combined mean mor-
tality for CTP class A, B, and C was 5.2%, 35.4%, and 70%, respec-
tively. Hence, the risk of mortality in patients with Child class B
and C is comparatively high.Journal of Hepatology 201Table 1 lists the mortality rates associated with speciﬁc types
of surgery in patients with cirrhosis stratiﬁed according to the
CTP scores. The overall operative mortality rates are maximal in
patients undergoing major open abdominal and cardiac surgery,
and these surgeries are contraindicated in Child C patients.
In recent years, the MELD score has been utilized to prioritize
organ allocation in patients awaiting LT. This score has also been
used to predict risk of mortality following surgery in CLD
patients. A MELD score 0–11 correlates with 5–10% 90-day mor-
tality, a score of 12–25 with 25–54% mortality rate, and scores
greater than 26 with a 90% postoperative mortality rate [20–
22,54]. Unlike the CTP score, which has subjective components,
the MELD score is considered more objective as it relies solely
on laboratory values, serum bilirubin, creatinine, and interna-
tional normalized ratio (INR). Northup et al. [54] noted in their
study that there was approximately a 1% increase in mortality
risk per MELD point below a score of 20, whereas there was a
2% increase in mortality risk per MELD point over 20. The c sta-
tistic of the MELD score for predicting 30-day mortality was
found to be 0.72 in the whole population of patients undergoing
surgery and 0.8 in the subgroup with intra-abdominal surgery.
The mean MELD score for patients dying was signiﬁcantly differ-
ent from patients who survived the non-hepatic surgical inter-
vention in this study. Also, in other studies, a MELD score of at
least 8 was shown to predict an increased risk of postoperative
complications, including death in patients undergoing cholecys-
tectomy [55].
Both CTP and MELD have been correlated with outcome of
patients with CLD. Several investigators gave birth to a ‘‘battle
for supremacy’’ between the CTP and MELD score to predict out-
comes of non-hepatic surgery in cirrhotic patients [20–22,54,56].
Befeler et al. [56] also showed the superiority of the MELD score
for extrahepatic general surgery in a group of 53 patients. MELD
score and plasma hemoglobin levels less than 10 g/dl were found
to be independent predictors of poor outcomes in this study. A
MELD score of 14 or greater was a better clinical predictor of poor
outcome than CTP class C (77% sensitivity, 80% speciﬁcity, 56%
positive predictive value and 91% negative predictive value).
Teh et al. [18] in the largest retrospective study of predictors of
perioperative mortality in patients with cirrhosis undergoing
abdominal, orthopaedic, and cardiovascular surgery found that
the MELD score, patient’s age, and ASA class were statistically2 vol. 57 j 874–884 877
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signiﬁcant predictors of mortality on multivariate analysis.
Whereas the ASA class was the best predictor of 7-day postoper-
ative mortality, the MELD score was the best predictor of 30-day,
90-day, and long-term postoperative mortality for all types of
surgery. An important ﬁnding of this study was that the relative
risk of 30- and 90-day mortality increased by 14% with each 1-
point increase in the MELD score. MELD score, along with patient
age and ASA class, was proposed as principal factor for risk
stratiﬁcation.
For now, clinicians should probably determine both the
Child’s class and the MELD score to estimate 30- and 90-day post-
operative mortality and morbidity rates in patients with cirrho-
sis. The CTP score includes additional important parameters like
ascites and portosystemic encephalopathy, which are not
included in the MELD score; on the other hand, the MELD score
includes creatinine which is an estimate of the renal function that
is often deranged in cirrhotic patients. The two scores should be
considered complementary rather than mutually exclusive, since
using both would give a better insight on the status of liver dis-
ease and degree of decompensation.
Are individual markers of organ function better than a single scoring
system?
While large populations of patients seem to be correctly prognos-
ticated using one or both of the grading systems (CTP andMELD), it
is evident that not all pathophysiologic conditions can be taken
into account by any single score. In addition, not considering acu-
ity of patient presentation and operative coursemay limit the abil-
ity of CTP and MELD scores to predict perioperative outcome [56].
Some individual markers of organ function may help in preop-
erative assessment, though there is no strong evidence yet to sug-
gest that individual risk factors are better than either CTP orTable 2. Series in literature on morbidity and mortality of non-hepatic abdominal s
Authors
Journal year; 
[Ref.]
Type of surgery Morbidity 
(%)
del Olmo JA et al., 
World J Surg. 2003; 
[6]
Non-hepatic abdominal 
surgery
50
Mansour A et al.,
Surgery 1997; 
[7]
Non-hepatic abdominal 
surgery
45
Zarski et al.,
Gastroenterol Clin Biol 1988; 
[86]
Extrahepatic digestive 
surgery
37
Wong R et al.,
J Am Coll Surg. 1994; 
[97]
Abdominal extrahepatic 
surgery
28 (major
Telem et al.,
Clin. Gastro. Hepatol. 2010; 
[87]
Abdominal extrahepatic 
surgery
43
Neeff H et al.,
J. Gastrointest. Surg. 2011; 
[88]
Non-hepatic general surgery -
PHT, portal hypertension; BP, blood pressure; ASA, American Society of Anesthesiologis
878 Journal of Hepatology 201MELD scores in assessing risk. In addition to parameters included
in the CTP and MELD scores, presence of PHT, hyponatremia,
infection, anemia, and malnutrition are other recognised individ-
ual risk factors. Semi-quantitative liver function tests including
galactose elimination capacity, aminopyrine breath test, indocya-
nine green (ICG) clearance, and monoethylglycinexylidide test
(MEGX) have also been proposed to risk-stratify patients with cir-
rhosis undergoing surgery, but these are not available universally
and hence not used routinely in clinical practice.
Tables 2 and 3 summarise important series in literature,
which studied the morbidity and mortality associated with vari-
ous non-hepatic intra-abdominal surgical procedures and tried to
identify prognostic factors.Preoperative interventions: Could they help make the surgery
safer?
Transjugular intrahepatic portosystemic shunt (TIPS)
The high morbidity and mortality after surgery in cirrhotic
patients is related to a great extent to the degree of PHT and
the occurrence of liver insufﬁciency in the postoperative period.
Preoperative portal decompression would seem to be a logical
approach to facilitate abdominal surgery and hopefully to
improve postoperative survival in these patients. TIPS reduces
the portosystemic gradient thus reducing the risk of bleeding,
and also helps reduce ascites, which is a signiﬁcant cause of post-
operative morbidity in these patients. TIPS placement is much
less invasive as compared to surgical shunts and it is possible
to do this procedure in patients with decompensated cirrhosis
(Child B) also, hence making it an option in this group of patients
[57].urgery in patients with cirrhosis.
Mortality 
(%)
Risk factors for morbidity/mortality
16.3 ~ Preoperative CTP score
~ Duration of surgery
~ Presence of postoperative 
general complications
50 in emergent,
18 in elective surgery
~ Emergency surgery
~ Preoperative Child-Pugh class
23 ~ Child-Pugh score esp. 
hypoalbuminemia
) 18 ~ Emergency surgery
~ Gastric procedures
~ Transfusion of FFP, platelets
7 ~ MELD ≥15
~ Serum albumin ≤2.5
~ Emergency surgery
~ Blood transfusions
35 after intra-abdominal 
procedures
~ Emergency surgery
~ Child-Pugh class
~ ASA class
~ Intraoperative transfusions 
~ Preoperative sodium <130
ts.
2 vol. 57 j 874–884
Table 3. Series in literature on morbidity and mortality in speciﬁc surgeries in patients with cirrhosis.
Author,
Journal year;
[Ref.]
Type of surgery Morbidity
(%)
Mortality
(%)
Risk factors for morbidity/mortality
Lehnert T et al.,
Ann Surg 1993;
[16]
Peptic ulcer surgery - ~ 29 in elective 
~ 35-64 in emergency
~ Preoperative Hb <12 g/L 
~ Systolic BP <100 mmHg 
~ Prothrombin time <60% 
~ Presence of PHT
Metcalf AM et al.,
Dis Colon Rectum 1987;
[89]
Colorectal surgery 24 48 Encephalopathy, ascites, anemia, 
hypoalbuminemia
Meunier K et al.,
Dis Colon Rectum 2008;
[90]
Colorectal surgery 77 26 ~ Preoperative ascites 
~ Postoperative infections
Nguyen GC et al.,
Dis Colon Rectum 2009;
[91]
Colorectal surgery - In-hospital
14 for cirrhotics, 
29 for cirrhotics with 
PHT
~ Presence of PHT 
~ Emergent/urgent surgery
Martinez JL et al.,
Surg Endosc 2004;
[92]
Laparoscopy assisted 
colorectal surgery
29 0 -
Lee JH et al.,
World J Gastroenterol 2005; 
[93]
Gastric cancer 39.4 3.8 ~ Child-Pugh class B, C
Jang HJ et al.,
Dig Dis Sci. 2008;
[94]
Gastric cancer 39 9 ~ Child-Pugh class B, C
Carbonell AM et al.,
Hernia 2005;
[95]
Abdominal wall hernias 16.5 2.5 ~ Co-morbidities – functional 
impairment, CHF, renal failure, 
~ Emergency surgery
Mc Kay A et al.,
Hernia 2009; 
[96]
Umbilical hernia repair 21 2.7 ~ Child-Pugh class
~ Emergency surgery
nutritional deficiencies, PVD
PHT, portal hypertension; BP, blood pressure; CHF, congestive heart failure; PVD, peripheral vascular disease.
JOURNAL OF HEPATOLOGYWe previously introduced the concept of preoperative TIPS to
increase safety of abdominal surgery in patients with severe PHT
[58]. Seven cirrhotic patients with PHT were planned for the fol-
lowing surgical interventions; colonic, gastro-oesophageal, renal,
and aortic procedures in three, two, one, and one patient, respec-
tively. Because PHT was a relative contraindication for surgery in
these patients, a ‘‘two-step strategy’’ was used: ﬁrst, TIPS to con-
trol PHT, followed by abdominal surgery at least 1 month later.
The TIPS procedure was successfully performed in all patients
without complications. The hepatic venous pressure gradient
decreased from 18 ± 5 to 9 ± 5 mmHg (p <0.01). All patients were
operated on with a delay ranging from 1 month to 5 months after
TIPS (2.9 ± 1.3 months; median 3 months). Patients with cancer
were operated on at 1 month post TIPS procedure. The planned
operation was performed in six of the seven patients. One patient
with cancer of the cardia could not undergo the planned proce-
dure because of intra-abdominal tumor dissemination detected
at exploratory laparotomy. Intraoperative transfusion was neces-
sary in only two of the six patients. One patient died, 36 days
after resection of a left colon cancer. We concluded that the
proposed two-step strategy in cirrhotic patients with severe
PHT could decrease morbidity and mortality after abdominal
surgery.
This concept was further used by Gil et al. [59] in three cir-
rhotic patients with severe PHT who had abdominal tumours
(colonic, gastric, and pancreatic tumours, respectively) requiringJournal of Hepatology 201surgical resection. In their small series, they concluded that TIPS
reduced the portosystemic gradient and the varices around the
tumoral area thus helping reduce bleeding and possible morbid-
ity due to the same. Schlenker et al. [60] also proposed that prep-
aration of patients with cirrhosis and PHT for elective surgery
using preoperative TIPS decreased the risk of perioperative mor-
bidity and mortality. Seven patients underwent gastric, colonic,
urological, and gynaecological surgeries with limited blood loss
and no operative mortality. However, since there was no compar-
ison group in this study, it was difﬁcult to determine which com-
plications could be best prevented using preoperative TIPS.
Vinet et al. [61] in their study evaluated the clinical outcomes
of 18 patients with cirrhosis who underwent non-hepatic abdom-
inal surgery after preoperative TIPS placement, a mean of 72 days
before surgery. TIPS induced a marked mean decrease in portohe-
patic gradient from 21.4 (±3.9) mmHg to 8.4 (±3.4) mmHg. Cir-
rhotic patients (n = 17) who underwent elective abdominal
surgery without preoperative TIPS placement were used as the
control group. Though the authors concluded that the preopera-
tive placement of TIPS had no positive effect on operative blood
loss, short and long term survival outcomes; it is of note that
the mean CTP score was signiﬁcantly higher in the TIPS group
(7.7 vs. 6.2), indicating that these patients were more decompen-
sated compared to controls. One would expect the more decom-
pensated patients to have a worse outcome following major
surgery.2 vol. 57 j 874–884 879
Table 4. Important parameters to look for and manage appropriately in patients with cirrhosis planned for non-hepatic surgery.
System Pathology Assessment Management
Abdomen Ascites
Increased risk of abdominal 
wound dehiscence, abdominal 
wall herniation, respiratory com-
promise, spontaneous bacterial 
peritonitis (SBP)
Check response to diuretics, pul-
monary function tests, diagnostic 
ascitic tap
~ Low sodium diet and diuretics with careful 
monitoring of creatinine and electrolyte levels
~ Large volume paracenthesis for uncontrolled 
ascites with albumin
~ Antibiotics for SBP
Renal
syndrome (HRS) due to drugs, 
infections, gastrointestinal bleed 
Renal function tests, creatinine 
clearance, DTPA scan
~ Avoid nephrotoxic drugs, contrast agents for 
diagnostic studies 
~ Combination of terlipressin, albumin in HRS
Central nervous 
system
Hepatic encephalopathy (HE) Clinical assessment, arterial am-
monia levels
~ Use of lactulose, metrogyl, branched chain 
amino acids 
~ Treat infections, avoid diuretics, constipation, 
CNS depressants, azotemia
Pulmonary Hydrothorax, hepatopulmonary 
syndrome (HPS), portopulmo-
nary hypertension (PPH)
~ Chest imaging
~ Bubble ECHO/MAA scan for 
HPS
~ Optimize pulmonary functions
been tried perioperatively
Cardiac Cardiomyopathy ~ Dobutamine stress ECHO
~ ACC and AHA guidelines for 
non-cardiac surgery
Beta blockers in perioperative period
Homeostasis Electrolyte disorders 
(esp. hyponatremia) arterial blood gases restriction, discontinuation of diuretics
Nutrition Malnutrition, hypoalbuminemia, 
muscle wasting, increased need 
for postoperative ventilation
Methodical nutritional assessment ~ Preoperative nutritional build-up (high carbo-
hydrate/lipid content, low in amino acid)
~ Vitamin B1 in alcoholics 
Other systems Anaemia and coagulopathy Intraoperative thrombo-elastogram Appropriate blood products perioperatively to 
maintain desired INR (<1.5), haemoglobin 
(>9 g%), platelet (>50,000/mm3) levels
Glucose intolerance Laboratory testing Insulin infusion
Gastroesophageal varices Endoscopy, portal pressure 
measurements
Βeta blockers, variceal banding
Concurrent infections Screening Antibiotic prophylaxis
Autoimmune hepatitis patients 
developing stress-induced insuf-
Serum cortisol levels Stress-dose steroids preoperatively
Renal insufficiency/hepatorenal
Regular electrolyte profile and Slow correction of serum sodium with fluid
~ Intravenous epoprostenol, sildenafil has also
~ Optimal fluid, electrolyte status
ficiency
ReviewKim et al. [62] reported results of surgery in patients with a
previously placed patent TIPS. Twenty-ﬁve cirrhotic patients with
a patent TIPS underwent abdominal (n = 19) or cardiothoracic
(n = 6) surgery at a single center. Thirty-two percent of surgeries
were emergent, 24% were urgent, and 44% were elective surger-
ies. Postoperatively, severe ascites developed in 29% and enceph-
alopathy in 17% of cases. During a median follow-up of
33 months, actuarial 1-year patient survival was 74%. The three
patients (12%) who died during their hospitalization all had
MELD scores P25 and had undergone emergency surgery.
Though, this study did not have a control group, the conclusion
was that portal decompression via TIPS may allow selected cir-
rhotic patients to safely undergo major surgery with an accept-
able rate of short-term morbidity and mortality.
In the study by Lian et al. [46], among the CLD patients with
IBD who underwent restorative proctocolectomy, two patients
underwent TIPS before total proctocolectomy/IPAA; both patients
did well in the postoperative period, none developed a pelvic
abscess or sepsis, which was the major cause of mortality in their
series.
In summary, it is true that at present there is not enough
evidence clearly supporting the use of TIPS before major abdom-880 Journal of Hepatology 201inal surgery in cirrhotic patients with severe PHT. Though a ran-
domised, controlled trial comparing outcomes in adequately
matched groups (with respect to CTP class and type of surgery)
will give the ﬁnal answer to the debate on whether preoperative
TIPS is beneﬁcial or not, such a trial is difﬁcult to design and
undertake.
Child A and early Child B patients (CTP score 5–7) [MELD score
625] with moderately well preserved liver function, yet having
signiﬁcant ascites, extensive abdominal varices, or both may be
ideal candidates for preoperative TIPS. The MELD score was orig-
inally developed to predict short term mortality in patients
undergoing TIPS, before being adopted by UNOS for prioritizing
organ allocation. With regard to its original utilization, a MELD
score <8 predicts good outcome after TIPS and a score >18 pre-
dicts poor outcome, with best outcomes seen in patients with
scores <14. Avoidance of TIPS is generally recommended in
patients with a MELD score >24, unless the procedure is used
as a measure of last resort to control active variceal bleeding.
Being a minimally invasive procedure, TIPS is not associated
with too many procedural complications in expert hands. Com-
plications like hepatic encephalopathy are the bane of TIPS, but
these are known to occur more commonly in severely decompen-2 vol. 57 j 874–884
Table 5. Recent reports on results of laparoscopic cholecystectomy in patients with liver cirrhosis (includes emergency and elective procedures).
Author, year [Ref.] Number of patients 
(n)
Morbidity
(n)
Mortality
(n)
A B C
Morino M et al., 2000 [77] 33 27 4 2 0 0
Fernandes NF et al., 2000 [11] 48 38 10 0 4 0
Clark JR et al., 2001 [79] 25 14 9 2 0 0
Yeh CN et al., 2002 [31] 226 193 33 0 15 2
Cucinotta E et al., 2003 [78] 22 12 10 0 14 0
Puggioni A et al., 2003 [81] 400 265 73 6 10 5
Curro G et al., 2007 [76] 50 35 15 0 15 0
Child-Pugh classification
JOURNAL OF HEPATOLOGYsated (Child C) patients. The placement of TIPS should be done at
least 2–4 weeks prior to the proposed surgical procedure
because, even though the drop in the portosystemic gradient is
immediate, the resolution of ascites (largely dependent on natri-
uresis) takes some time. Consequently, a cirrhotic patient need-
ing emergent surgery would not beneﬁt from TIPS.Preparing a cirrhotic patient for surgery
Common pathology in chronic liver disease patients to be looked for
and managed preoperatively
Table 4 shows the common complications and morbid conditions
that frequently co-exist in patients with CLD, they need to be
identiﬁed and adequately treated in order to ensure a smooth
operative and postoperative course. Primary issues to anticipate
and address include manifestations of acute liver decompensa-
tion including encephalopathy, acute renal failure, coagulopathy,
adult respiratory distress syndrome, and sepsis [63,64]. In addi-
tion, cardiovascular and nutritional status, and ﬂuid and electro-
lyte balance need to be optimized so as to decrease perioperative
death and complications after surgery.
In general, it is accepted that converting a Child C patient to
Child B preoperatively could help survival after surgery [65].
Coagulopathy and thrombocytopenia should be corrected with
replenishment of vitamin K, administration of fresh-frozen
plasma (FFP), and possibly cryoprecipitate transfusions to reduce
a prothrombin time within 3 s of normal time and to achieve a
goal of platelet counts >50,000/mm3. Infection, diuretics, meta-
bolic alkalosis, constipation, CNS depressants, hypoxia, sepsis,
azotemia, or gastrointestinal bleeding in the pre/postoperative
periods may induce encephalopathy. Thus, correction of electro-
lyte imbalance, treatment of infection, branched chain amino acid
therapy, and restriction of sedatives help prevent encephalopathy
[66,67].
With respect to the etiology of cirrhosis, patients with auto-
immune hepatitis on daily steroids should receive stress-dosed
steroids before surgery. D-penicillamine can impair wound heal-
ing; patients taking it for Wilson disease should decrease their
dose for 1–2 weeks pre and postoperatively. As mentioned
before, CLD patients with a history of alcohol abuse are at
increased risk of other complications, including poor wound heal-
ing, bleeding, delirium, and infections. Patients who have contin-
ued to actively drink are at risk for withdrawal. Unless theJournal of Hepatology 201surgery is imminent, patients with alcoholic hepatitis should
have medical management and be stabilised, or should undergo
alternative, less invasive procedures in an emergency situation.Role of laparoscopic surgery in patients with cirrhosis
Cirrhosis was once considered to be a contraindication for the
laparoscopic approach. A major difference of open and laparo-
scopic procedures is the creation of pneumoperitoneum for visu-
alisation of the abdominal cavity. Theoretically, for reasons cited
above, pneumoperitoneum is considered unsafe for abdominal
surgery in CLD patients as they already have varying degrees of
alterations in hepatic blood ﬂow and general haemodynamics.
However, within the limits of our literature search, no report of
hepatic failure attributable to laparoscopy alone in a cirrhotic
patient was found. Also, current literature has increasingly shown
that the use of laparoscopy in the treatment of various disease
speciﬁc and disease non-speciﬁc surgical conditions in cirrhotic
patients is safe and offers many advantages [68–71].
Some authors have advocated modiﬁcations in operative tech-
niques to help minimise the morbidity in CLD patients undergo-
ing laparoscopic procedures. Friel et al. [72] advocated the use of
open technique using Hassan’s trocar for access, to prevent inad-
vertent puncture of an umbilical varix, whereas placement of the
trocar in the right paramedian position when umbilical varix is
already present was proposed by Schiff [73]. In addition, certain
modiﬁcations in the surgical technique have been suggested to
make particular procedures safer as detailed below.
Laparoscopic cholecystectomy in cirrhotic patients
Open cholecystectomy (OC) in cirrhotic patients continues to be
associated with high rates of morbidity (5–30%) and mortality
(7–25%) compared to 0.5–1% mortality in non-cirrhotics [74,75].
With increasing experience, several centers across the world have
demonstrated that laparoscopic cholecystectomy (LC) is safe and
effective with fewer complications compared to OC [11,31,76–
79,81] (Table 5).
Speciﬁcally, LC is associated with less intraoperative bleeding
and shorter duration of hospital stay and fewer postoperative
complications. It is also particularly useful in LT candidates since
it is associated with fewer postoperative adhesions [11].
Certain problems may be encountered during laparoscopic
cholecystectomy in patients with a cirrhotic liver. There may be2 vol. 57 j 874–884 881
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difﬁculty with traction of the liver, inadequate exposure of the
hilum, adhesions around the gallbladder and the hilum with dif-
ﬁculty in identifying anatomical landmarks as well as increased
vascularity of the gallbladder bed. The use of additional ports,
as well as performance of retrograde cholecystectomy or modi-
ﬁed subtotal cholecystectomy in cases of severe inﬂammation
leaving the back wall of the gallbladder on the liver bed in
selected cases, can be helpful [79]. The use of mechanical com-
pression from introduced surgical sponges to achieve haemosta-
sis with additional haemostatic modalities such as oxidized
cellulose, topical haemostatic agents, application of ultrasonic
energy via a harmonic scalpel and the use of argon beam coagu-
lator, which can be inserted through an operative port, have also
been described [72].
Palanivelu et al. [80] reported their experience with 265 lapa-
roscopic cholecystectomies in Child–Pugh A and B cirrhotic
patients, with symptomatic gallstones. There was no mortality;
in 15% of patients, postoperative deterioration in liver function
occurred. They concluded that amodiﬁcation of subtotal cholecys-
tectomy should be practiced, depending on the risk factors pres-
ent, to avoid complications in these high risk cirrhotic patients.
A meta-analysis of LC in cirrhotic patients, [81] was inconclu-
sive in recommending LC for CTP class C patients due to inconclu-
sive data in most of the studies reviewed. It is not clear whether
many surgeons consider the risks of morbidity and mortality to
be so high as to withhold even emergency surgeries in these
patients or that the data on this group of patients are not
included in the different publications. It would seem that indica-
tions for surgery in these patients should be limited to emergen-
cies such as cholecystectomy for acute cholecystitis. Even in such
instances, percutaneous drainage of the gallbladder and other
conservative procedures may sufﬁce [82].
Laparoscopic hernia repair in cirrhosis
In a report of 14 cirrhotic patients who underwent laparoscopic
incisional and umbilical hernia repair, Giulio et al. [68] observed
that though open repair in cirrhotic patients has signiﬁcant recur-
rence rates and frequent wound infections, laparoscopic repair
yields less morbidity and fewer recurrences. The study further
highlighted that the preservation of the anterior abdominal wall
in laparoscopic repair avoided the interruption of collateral veins,
which are not infrequently distended in cirrhotic patients.
Successful laparoscopic repair of recurrent incarcerated
umbilical hernia in a cirrhotic patient with refractory ascites
has also been reported [83]. In the report, the authors used dual
mesh prosthesis and advocated meticulous sterile fashion of
mesh insertion and ﬁxation. This is important since ascitic ﬂuid
infection, which may occur after surgery may affect the hernia
mesh repair. The possibility of mesh migration due to the ascitic
ﬂuid can be reduced by placing the mesh in a preperitoneal space
[84].
Other laparoscopic procedures in cirrhotic patients
Cobb et al. [69] reported 52 laparoscopic procedures performed
on 50 cirrhotic patients These procedures, including cholecystec-
tomies, splenectomies, colectomies, diagnostic laparoscopies,
ventral hernia repairs, Nissen fundoplication, Heller’s myotomy,
gastric bypass and radical nephrectomy, had a morbidity rate of
16% but no mortality.882 Journal of Hepatology 201Tsugawa et al. [43] had earlier compared open and laparo-
scopic appendectomies among patients with liver cirrhosis. They
reported fewer complications with the laparoscopic approach.
Gentileschi [85] reported a successful laparoscopic suture clo-
sure and placement of an omental patch for treatment of a perfo-
rated gastric ulcer with peritonitis in a severely cirrhotic patient
(Child C) with PHT.
To summarise, laparoscopy in cirrhotic patients is associated
with a deﬁnite risk, yet is not signiﬁcant enough to contraindicate
the procedure in these patients. Many studies have also shown
that laparoscopy is not only safe in carefully selected cirrhotic
patients but also has many advantages over the various open pro-
cedures. However, its safety in Child-Pugh’s class C patients is not
yet proven hence surgery in such patients may be limited to con-
servative procedures in emergency cases.Conclusions
The perioperative morbidity and mortality following non-hepatic
surgical procedures in patients with cirrhosis are signiﬁcant, with
mortality rates of up to 50% reported following surgery in
patients with decompensated CLD. Stringent assessment of these
patients for co-morbidities and risk stratiﬁcation in the preoper-
ative period is essential if their outcomes are to be improved.
Considering both, the Child score and MELD score to prognosti-
cate these patients as regards short term outcomes seems to be
necessary as of now.
Three factors essentially determine the extent of surgical risk;
degree of decompensation (higher MELD and CTP score), whether
the surgery is performed as an emergency procedure or elec-
tively, and the nature/type of surgery. Since PHT is an added risk
factor for non-hepatic abdominal surgery, preoperative portal
decompression may help reduce the difﬁculty of the surgical pro-
cedure especially as regards intraoperative bleeding, and may
also reduce morbidity and mortality by decreasing the ascites if
done relatively well in advance of the planned procedure. Though
evidence and safety to support the approach in all eligible CLD
patients are not strong enough at this point in time, the concept
of a two-stage strategy initially proposed and used by us may
help improve perioperative outcomes following non-hepatic
abdominal surgery in well selected patients with compensated
cirrhosis and severe PHT.Conﬂict of interest
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